Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
Q3 2024 vs. Q2 2024
How the institutions holding Calidi Biotherapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 32 | 1 | 20 | −11 |
| SharesConverted for a 1-for-10 split | 268.2K | 258.8 | 319.3K | +51.4K (+19.2%) |
| Value | $523.2K | $518 | $363.4K | −$159.3K (−30.5%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 39,612 | $45.2K | 0.00% |
| Susquehanna International Group, LLP | 23,544 | $26.8K | 0.00% |
| Apollo Management Holdings, L.P. | 12,500 | $14.3K | 0.00% |
| Evermay Wealth Management LLC | 6,342 | $7.23K | 0.00% |
| BlackRock, Inc. | 259 | $295 | 0.00% |
| FMR LLC | 141 | $161 | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 500 | $0 | 0.00% |
Sold out (18)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| RS Crum Inc. | 263,470 | $52.7K |
| Citadel Advisors LLC | 125,905 | $25.2K |
| HRT Financial LP | 101,390 | $20.0K |
| Driehaus Capital Management LLC | 94,697 | $18.9K |
| Polar Asset Management Partners Inc. | 125,000 | $12.8K |
| Marshall Wace, LLP | 61,869 | $12.4K |
| Governors Lane LP | 47,349 | $9.47K |
| XTX Topco Ltd | 42,964 | $8.59K |
| Magnetar Financial LLC | 33,638 | $6.31K |
| Virtu Financial LLC | 25,965 | $5.00K |
| DLK Investment Management, LLC | 20,812 | $4.16K |
| Vanguard Group Inc | 14,939 | $2.99K |
| State Street Corp | 12,900 | $2.58K |
| Two Sigma Securities, LLC | 11,132 | $2.23K |
| Financial Counselors Inc | 10,000 | $2.00K |
| Creative Planning | 10,000 | $2.00K |
| Cetera Investment Advisers | 10,000 | $2.00K |
| The PNC Financial Services Group, Inc. | 100 | $20 |
Not filed for Q3 2024 yet (1)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 2,588 | $518 |